Factor VIII and von Willebrand activity are strongly related to the desmopressin biological response in von willebrand disease

被引：0
|
作者：
Sanchez-Luceros, A. [1 ]
Woods, A., I [2 ]
Meschengieser, S. S. [3 ]
Grosso, S. [3 ]
Lazzari, M. A. [1 ]
机构：
[1] Acad Nacl Med Buenos Aires, CONICET, Hemostasia & Trombosis, Buenos Aires, DF, Argentina
[2] Acad Nacl Med Buenos Aires, CONICET, Buenos Aires, DF, Argentina
[3] Acad Nacl Med Buenos Aires, Hemostasia & Trombosis, Buenos Aires, DF, Argentina
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-MO-613
引用
收藏
页码：528 / 528
页数：1
相关论文
共 50 条
  • [41] Acquired von willebrand syndrome and response to desmopressin
    Biguzzi, E.
    Franchi, F.
    Siboni, S. M.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 103 - 103
  • [42] Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity
    Lasne, D.
    Dey, C.
    Dautzenberg, M. -D.
    Cherqaoui, Z.
    Monge, F.
    Aouba, A.
    Torchet, M. -F.
    Geloen, D.
    Landais, P.
    Rothschild, C.
    HAEMOPHILIA, 2012, 18 (03) : e158 - e163
  • [43] Factor VIII/von Willebrand factorDevelopment of alloantibodies against von Willebrand factor: case report
    Reactions Weekly, 2012, 1426 (1) : 23 - 23
  • [44] Dose linearity of von Willebrand factor factor VIII concentrate in elective surgery in von Willebrand disease patients.
    Mannucci, PM
    Kyrle, PA
    Schulman, S
    Haertel, S
    Lethagen, S
    BLOOD, 2003, 102 (11) : 312A - 312A
  • [45] Use of von Willebrand Factor Concentrate in Inherited von Willebrand Disease: How Often Is It Useful to Add Factor VIII?
    Drillaud, Nicolas
    Ardillon, Laurent
    Ternisien, Catherine
    Valentin, Jean Baptiste
    Trossaert, Marc
    TRANSFUSION MEDICINE REVIEWS, 2020, 34 (02) : 128 - 129
  • [46] Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys
    Federici, AB
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 : S17 - S21
  • [47] Comparative analysis and classification of von Willebrand factor/factor VIII concentrates:: Impact on treatment of patients with von Willebrand disease
    Budde, Ulrich
    Metzner, Hubert J.
    Mueller, Heinz-Georg
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (06): : 626 - 635
  • [48] Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study
    Heijdra, Jessica M.
    Cloesmeijer, Michael E.
    de Jager, Nico C. B.
    Leebeek, Frank W. G.
    Kruip, Marieke H. J. A.
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    HAEMOPHILIA, 2022, 28 (05) : 814 - 821
  • [49] INHIBITION OF WILLEBRAND FACTOR IN VON WILLEBRAND DISEASE
    MARAGALL, S
    CASTILLO, R
    ORDINAS, A
    LIENDO, F
    RODRIGUEZ, M
    THROMBOSIS RESEARCH, 1979, 14 (2-3) : 495 - 500
  • [50] Modification of factor VIII-von Willebrand factor binding activity assay for diagnosis of von Willebrand disease type 2N
    Zhukov, O. S.
    Popov, J.
    Ramos, R.
    Huebner, A.
    Ruden, S.
    Sferruzza, A.
    Dlott, J.
    Sahud, M.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A139 - A139
12345